Venus Medtech Inc., the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company focused on developing transcatheter mitral and tricuspid valve replacement products for patients undergoing mitral and tricuspid valve disease, announced a partnership agreement to develop, manufacture and sell these TMVR and TTVR products in Greater China.